Literature DB >> 25969534

Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells.

Yun Teng1, Brandie N Radde1, Lacey M Litchfield1, Margarita M Ivanova1, Russell A Prough1, Barbara J Clark1, Mark A Doll2, David W Hein2, Carolyn M Klinge3.   

Abstract

Little is known about the regulation of the oncomiR miR-21 in liver. Dehydroepiandrosterone (DHEA) regulates gene expression as a ligand for a G-protein-coupled receptor and as a precursor for steroids that activate nuclear receptor signaling. We report that 10 nm DHEA increases primary miR-21 (pri-miR-21) transcription and mature miR-21 expression in HepG2 cells in a biphasic manner with an initial peak at 1 h followed by a second, sustained response from 3-12 h. DHEA also increased miR-21 in primary human hepatocytes and Hep3B cells. siRNA, antibody, and inhibitor studies suggest that the rapid DHEA-mediated increase in miR-21 involves a G-protein-coupled estrogen receptor (GPER/GPR30), estrogen receptor α-36 (ERα36), epidermal growth factor receptor-dependent, pertussis toxin-sensitive pathway requiring activation of c-Src, ERK1/2, and PI3K. GPER antagonist G-15 attenuated DHEA- and BSA-conjugated DHEA-stimulated pri-miR-21 transcription. Like DHEA, GPER agonists G-1 and fulvestrant increased pri-miR-21 in a GPER- and ERα36-dependent manner. DHEA, like G-1, increased GPER and ERα36 mRNA and protein levels. DHEA increased ERK1/2 and c-Src phosphorylation in a GPER-responsive manner. DHEA increased c-Jun, but not c-Fos, protein expression after 2 h. DHEA increased androgen receptor, c-Fos, and c-Jun recruitment to the miR-21 promoter. These results suggest that physiological concentrations of DHEA activate a GPER intracellular signaling cascade that increases pri-miR-21 transcription mediated at least in part by AP-1 and androgen receptor miR-21 promoter interaction.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G-protein-coupled receptor (GPCR); estrogen receptor; gene transcription; hormones; microRNA (miRNA); microRNA biogenesis

Mesh:

Substances:

Year:  2015        PMID: 25969534      PMCID: PMC4505488          DOI: 10.1074/jbc.M115.641167

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction.

Authors:  Angelina Wallacides; Amand Chesnel; Hussein Ajj; Martine Chillet; Stéphane Flament; Héène Dumond
Journal:  Mol Cell Endocrinol       Date:  2011-11-25       Impact factor: 4.102

2.  Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach.

Authors:  George Notas; Marilena Kampa; Vassiliki Pelekanou; Elias Castanas
Journal:  Steroids       Date:  2011-11-26       Impact factor: 2.668

3.  Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway.

Authors:  Tommaso Simoncini; Camila Scorticati; Paolo Mannella; Ahmed Fadiel; Maria S Giretti; Xiao-Dong Fu; Chiara Baldacci; Silvia Garibaldi; Antonella Caruso; Letizia Fornari; Frederick Naftolin; Andrea R Genazzani
Journal:  Mol Endocrinol       Date:  2006-04-06

4.  miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.

Authors:  Qin Zhu; Zhiming Wang; Yu Hu; Jindong Li; Xinying Li; Ledu Zhou; Yun Huang
Journal:  Oncol Rep       Date:  2012-02-09       Impact factor: 3.906

5.  Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs).

Authors:  Weiwei Yang; Yan Lu; Yichen Xu; Lizhi Xu; Wei Zheng; Yuanyuan Wu; Long Li; Pingping Shen
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

6.  In vivo effects of a GPR30 antagonist.

Authors:  Megan K Dennis; Ritwik Burai; Chinnasamy Ramesh; Whitney K Petrie; Sara N Alcon; Tapan K Nayak; Cristian G Bologa; Andrei Leitao; Eugen Brailoiu; Elena Deliu; Nae J Dun; Larry A Sklar; Helen J Hathaway; Jeffrey B Arterburn; Tudor I Oprea; Eric R Prossnitz
Journal:  Nat Chem Biol       Date:  2009-06       Impact factor: 15.040

7.  Dehydroepiandrosterone induces growth arrest of hepatoma cells via alteration of mitochondrial gene expression and function.

Authors:  Hung-Yao Ho; Mei-Ling Cheng; Hsin-Yu Chiu; Shiue-Fen Weng; Daniel Tsun-Yee Chiu
Journal:  Int J Oncol       Date:  2008-11       Impact factor: 5.650

Review 8.  Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS.

Authors:  Prasenjit Dey; Rodrigo P A Barros; Margaret Warner; Anders Ström; Jan-Åke Gustafsson
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

9.  Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.

Authors:  Rainer Girgert; Günter Emons; Carsten Gründker
Journal:  Breast Cancer Res Treat       Date:  2012-07       Impact factor: 4.872

10.  Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes.

Authors:  Yasumasa Ikeda; Soichiro Tajima; Yuki Izawa-Ishizawa; Yoshitaka Kihira; Keisuke Ishizawa; Shuhei Tomita; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

View more
  18 in total

1.  Effect of estrogen-active compounds on the expression of RACK1 and immunological implications.

Authors:  Erica Buoso; Mirco Masi; Valentina Galbiati; Ambra Maddalon; Martina Iulini; Maša Kenda; Marija Sollner Dolenc; Marina Marinovich; Marco Racchi; Emanuela Corsini
Journal:  Arch Toxicol       Date:  2020-04-23       Impact factor: 5.153

Review 2.  Estrogens regulate life and death in mitochondria.

Authors:  Carolyn M Klinge
Journal:  J Bioenerg Biomembr       Date:  2017-08       Impact factor: 2.945

Review 3.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

4.  Role of purinergic receptors in hepatobiliary carcinoma in Pakistani population: an approach towards proinflammatory role of P2X4 and P2X7 receptors.

Authors:  Arun Asif; Madiha Khalid; Sobia Manzoor; Hassam Ahmad; Aman Ur Rehman
Journal:  Purinergic Signal       Date:  2019-08-10       Impact factor: 3.765

5.  The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.

Authors:  Melania E Mercado-Pimentel; Benjamin C Onyeagucha; Qing Li; Angel C Pimentel; Jana Jandova; Mark A Nelson
Journal:  FEBS Lett       Date:  2015-07-17       Impact factor: 4.124

6.  Increased serum concentrations of estrogen-induced growth factors Midkine and FGF2 in NF1 patients with plexiform neurofibroma.

Authors:  Isis Atallah; Ana M Cieza Rivera; Octavio M Rivero Lezcano; Laura Tascón-González; Carolina González-Cortés; Cristina Diez Tascón; Tania Fernández-Villa; Vicente Martín
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

7.  Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.

Authors:  Minqian Shen; Haifei Shi
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

8.  Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma.

Authors:  J-Y Chuang; W-L Lo; C-Y Ko; S-Y Chou; R-M Chen; K-Y Chang; J-J Hung; W-C Su; W-C Chang; T-I Hsu
Journal:  Oncogenesis       Date:  2017-05-22       Impact factor: 7.485

9.  Antioxidant Protection of NADPH-Depleted Oligodendrocyte Precursor Cells Is Dependent on Supply of Reduced Glutathione.

Authors:  Ewa Kilanczyk; Sujata Saraswat Ohri; Scott R Whittemore; Michal Hetman
Journal:  ASN Neuro       Date:  2016-07-21       Impact factor: 4.146

10.  HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.

Authors:  Belinda J Petri; Kellianne M Piell; Gordon C South Whitt; Ali E Wilt; Claire C Poulton; Norman L Lehman; Brian F Clem; Matthew A Nystoriak; Marcin Wysoczynski; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2021-07-14       Impact factor: 9.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.